BriaCell Therapeutics (BCTXW) Stock Chart & Stock Price History $0.10 -0.03 (-22.78%) As of 05/21/2025 03:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BriaCell Therapeutics Stock Price Performance The BriaCell Therapeutics (BCTXW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 80.77%, with a year-to-date return of -65.46%. In the past month, the stock has decreased 22.48%, reflecting recent market activity. As of the latest close, BriaCell Therapeutics traded at $0.10 with a market cap of and volume of 53,009 shares. Receive BCTXW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+44.51%1 Month Performance-22.48%3 Month Performance-10.71%Year-To-Date Performance-65.46%1 Year Performance-80.77% BCTXW Stock Chart for Thursday, May, 22, 2025 BCTXW Chart by TradingView BriaCell Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$0.13$0.10-22.78%$0.10$0.0953,009 shs$0.0005/20/2025$0.08$0.13+66.24%$0.13$0.05861,061 shs$0.0005/19/2025$0.07$0.08+12.57%$0.08$0.0721,065 shs$0.0005/16/2025$0.05$0.07+39.24%$0.07$0.0521,820 shs$0.0005/15/2025$0.05$0.05+0.61%$0.06$0.0272,807 shs$0.0005/14/2025$0.06$0.05-17.11%$0.06$0.0416,542 shs$0.0005/13/2025$0.07$0.06-14.24%$0.06$0.0428,831 shs$0.0005/12/2025$0.07$0.07+6.92%$0.07$0.053,600 shs$0.0005/09/2025$0.07$0.07-4.27%$0.07$0.071,010 shs$0.0005/08/2025$0.08$0.07-11.01%$0.08$0.0524,228 shs$0.00 Get the Latest News and Ratings for BCTXW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$0.09$0.08-13.49%$0.09$0.05101,155 shs$0.0005/06/2025$0.11$0.09-20.75%$0.10$0.0850,893 shs$0.0005/05/2025$0.11$0.11+2.11%$0.12$0.1021,926 shs$0.0005/02/2025$0.11$0.11-3.11%$0.11$0.106,722 shs$0.0005/01/2025$0.12$0.11-6.25%$0.13$0.111,679 shs$0.0004/30/2025$0.12$0.12-0.83%$0.13$0.1016,057 shs$0.0004/29/2025$0.12$0.12+1.68%$0.15$0.1150,209 shs$0.0004/28/2025$0.13$0.12-9.57%$0.15$0.11197,042 shs$0.0004/25/2025$0.17$0.13-22.86%$0.16$0.10487,443 shs$0.0004/24/2025$0.14$0.17+22.73%$0.25$0.15797,223 shs$0.0004/23/2025$0.13$0.14+7.75%$0.15$0.09121,058 shs$0.0004/22/2025$0.09$0.13+43.49%$0.14$0.07400,450 shs$0.0004/21/2025$0.06$0.09+40.03%$0.09$0.0618,467 shs$0.00 Related Companies 180 Life Sciences Stock Chart 4D pharma Stock Chart Aesther Healthcare Acquisition Stock Chart Ainos Stock Chart Alvotech Stock Chart Atlantic Coastal Acquisition Corp. II Stock Chart Biofrontera Stock Chart biote Stock Chart Celularity Stock Chart Cingulate Stock Chart Receive BCTXW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCTXW) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
